Managing Director Dr. Christine Meyer will speak on “Generics Exclusion: What Conduct Crosses the Lines?” at 2:00 pm EDT on 1 July 2020. Dr. Meyer and other panelists will discuss product hoping, patent settlement, and class certification at the inaugural joint Concurrences and Fordham Law School Antitrust in Life Sciences webinar series.

Read Dr. Meyer's interview with the moderator, Martin Gaynor, Professor of Economics & Health Policy at Carnegie Mellon University here. Dr. Meyer and Professor Gaynor discuss transparency of pharmaceutical pricing, use of the illusion of innovation, and the availability and affordability of pharmaceuticals.